-
This is the first new drug approved for Alzheimer's disease since 2003. It's the first to show significant progress against the sticky brain plaques that are the hallmark of Alzheimer's disease.
-
Researchers are looking to enroll 7,600 people for the study into whether computer-based cognitive training can prevent and even improve disorders such as dementia and Alzheimer’s disease.
-
An experimental medicine seems to ease symptoms of Fragile X syndrome, a genetic disorder that is the most common inherited cause of intellectual disabilities and autism.
-
Long-term care residents’ participation in the vaccination effort is clouded by a significant complication: More than half have cognitive impairment or dementia.
-
Researchers launched a major study of an experimental Alzheimer's drug this summer. They also learned a lot about how to protect participants who must make frequent visits to a medical center.
-
As the pandemic changes its day-to-day operations, a new executive director takes over the eleven-county agency.
-
Daisy Conant, 91, thrives off routine.One of her favorites is reading the newspaper with her morning coffee. But, lately, the news surrounding the…
-
Two new human studies back earlier hints that vaccines designed to prevent respiratory infections might also provide some protection against Alzheimer's disease.
-
Structures inside healthy brain cells nimbly move from one state to the next to perform different functions. But in certain degenerative brain diseases, scientists now think, that process gets stuck.
-
After a decade of failure in treating Alzheimer's with drugs, the National Institutes of Health is funding a five-year effort in Seattle to learn more about how the disease starts in the brain.